Sign up to save your podcasts
Or
Share Groundbreaking Steps in Melanoma Monitoring with Digital PCR Tests: Dr. Claudia Scheckel, Oncobit
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Groundbreaking Steps in Melanoma Monitoring with Digital PCR Tests: Dr. Claudia Scheckel, Oncobit
Adjusting cancer treatment might feel like searching in the dark. There are so many unknowns.
Have a glimpse into the future of cancer care – in this episode, with regards to skin cancer melanoma.
Adding to body scans in search for melanoma methastases, a digital PCR test can be used to detect a melanoma BRAF E600 marker. Meaning: a blood sample that can be tested once a week, instead of PET scan once every three months to allow more personalised cancer treatment and adjust medication according to efficiency.
What we're speaking is also much earlier detection of methastases than current methods.
You’ll hear about
- skin cancer
- melanoma markers
- PCR test for melanoma stages
- the difference between PCR and digital PCR
- an agile startup in a slower moving hospital environment.
Dr. Claudia Scheckel is a CEO of Oncobit. A biochemist that worked for almost a decade in biomedical research at the Rockefeller University in New York and University Hospital Zurich, Switzerland.
Oncobit is a Swiss startup developing precision monitoring assays for personalized cancer care. Their platform provides a rapid quantification of circulating melanoma tumor DNA, hence supports patients and doctors in adjusting for the optimal treatment.
More details:
https://oncobit.com/en
Timestamps:
0:00 Dr. Claudia Scheckel and Oncobit
1:10 Melanoma Risk Factor, Countries
2:37 Melanoma Diagnosis
4:45 What Happens After Melanoma Diagnosis, Melanoma Stages
12:39 Minimally Invasive Melanoma Monitoring Solution
13:47 What is PCR, Difference Between PCR and Digital PCR
19:21 Digital PCR in Cancer Monitoring
27:22 Founding a Healthcare Startup
35:38 Building a Startup in Cancer Monitoring
44:12 Follow X-Health.show, Disclaimer
If you've enjoyed listening, you'll make us happy by clicking "Follow" on X-Health.show and leaving a review.
The information in this podcast is for informational purposes only and should not be considered medical advice. If you have any medical questions, please consult your healthcare practitioner. The opinions on the show are Alex's or her guests. The podcast does not make any responsibility or warranties about guests statements or credibility. While the podcast makes every effort to ensure that the information shared is accurate, please let us know if you have any comments, suggestions or corrections.
View all episodes
By Alex Jani: interviewing visionaries of healthcare innovationAdjusting cancer treatment might feel like searching in the dark. There are so many unknowns.
Have a glimpse into the future of cancer care – in this episode, with regards to skin cancer melanoma.
Adding to body scans in search for melanoma methastases, a digital PCR test can be used to detect a melanoma BRAF E600 marker. Meaning: a blood sample that can be tested once a week, instead of PET scan once every three months to allow more personalised cancer treatment and adjust medication according to efficiency.
What we're speaking is also much earlier detection of methastases than current methods.
You’ll hear about
- skin cancer
- melanoma markers
- PCR test for melanoma stages
- the difference between PCR and digital PCR
- an agile startup in a slower moving hospital environment.
Dr. Claudia Scheckel is a CEO of Oncobit. A biochemist that worked for almost a decade in biomedical research at the Rockefeller University in New York and University Hospital Zurich, Switzerland.
Oncobit is a Swiss startup developing precision monitoring assays for personalized cancer care. Their platform provides a rapid quantification of circulating melanoma tumor DNA, hence supports patients and doctors in adjusting for the optimal treatment.
More details:
https://oncobit.com/en
Timestamps:
0:00 Dr. Claudia Scheckel and Oncobit
1:10 Melanoma Risk Factor, Countries
2:37 Melanoma Diagnosis
4:45 What Happens After Melanoma Diagnosis, Melanoma Stages
12:39 Minimally Invasive Melanoma Monitoring Solution
13:47 What is PCR, Difference Between PCR and Digital PCR
19:21 Digital PCR in Cancer Monitoring
27:22 Founding a Healthcare Startup
35:38 Building a Startup in Cancer Monitoring
44:12 Follow X-Health.show, Disclaimer
If you've enjoyed listening, you'll make us happy by clicking "Follow" on X-Health.show and leaving a review.
The information in this podcast is for informational purposes only and should not be considered medical advice. If you have any medical questions, please consult your healthcare practitioner. The opinions on the show are Alex's or her guests. The podcast does not make any responsibility or warranties about guests statements or credibility. While the podcast makes every effort to ensure that the information shared is accurate, please let us know if you have any comments, suggestions or corrections.